scispace - formally typeset
L

Lifeng Qi

Researcher at Tongji University

Publications -  21
Citations -  3018

Lifeng Qi is an academic researcher from Tongji University. The author has contributed to research in topics: Biology & Internal medicine. The author has an hindex of 11, co-authored 16 publications receiving 2697 citations. Previous affiliations of Lifeng Qi include California NanoSystems Institute & West Virginia University.

Papers
More filters
Journal ArticleDOI

Preparation and antibacterial activity of chitosan nanoparticles.

TL;DR: Results show that chitosan nanoparticles and copper-loaded nanoparticles could inhibit the growth of various bacteria tested and exposed to S. choleraesuis led to the disruption of cell membranes and the leakage of cytoplasm.
Journal ArticleDOI

Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

TL;DR: The rational design of multifunctional nanoparticles for short-interfering RNA (siRNA) delivery and imaging based on the use of semiconductor quantum dots (QDs) and proton-absorbing polymeric coatings (proton sponges) are reported, demonstrating dramatic improvement in gene silencing efficiency and simultaneous reduction in cellular toxicity.
Journal ArticleDOI

Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA.

TL;DR: A new generation of nanoparticle carrier that allows efficient delivery and real-time imaging of siRNA in live cells has been developed by combining two distinct types of nanomaterials, semiconductor quantum dots and amphipols.
Journal ArticleDOI

Lead sorption from aqueous solutions on chitosan nanoparticles

TL;DR: In this article, the physicochemical properties of chitosan nanoparticles were characterized by size and zeta-potential analyzer, atomic force microscopy, FTIR spectra, and X-ray powder diffraction.
Journal ArticleDOI

Emerging application of quantum dots for drug delivery and therapy.

TL;DR: This fluorescent ‘prototype’ will provide important information in the rational design of biocompatible drug carriers and will serve as a superior alternative to magnetic and radioactive imaging contrast agents in preclinical drug screening, validation and delivery research.